Trial Site Detail

 

Drug:
Imatinib + RAD001
Trial:
Treatment of Patients With Everolimus and Imatinib Mesylate Who Have Progressive Gastro Intestinal Stromal Tumors (GIST) and Are Resistant to Imatinib Mesylate
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Site name unknown, Dusseldorf

     
Dusseldorf ,
Germany

 

Principal Investigator:
Contact:
Activation Status of this Site:
Closed
Notes about this Site:
Site name unknown, Dusseldorf Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.